v3.26.1
Consolidated Statements of Shareholders’ Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Capital Surplus
Retained Earnings
Accumulated Other Comprehensive Income (Loss), Net of Tax
Treasury Stock
Common stock, balance at beginning of period (in shares) at Dec. 31, 2024   72,699,245        
Balance at beginning of period at Dec. 31, 2024 $ 3,751,522 $ 72,699 $ 1,958,642 $ 1,853,428 $ (30,119) $ (103,128)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2024           3,630,636
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted shares (in shares)   88,841        
Issuance of restricted shares 0 $ 88 (88)      
Issuance of common shares pursuant to PSU agreements (in shares)   122,904        
Issuance of common shares pursuant to PSU agreements 0 $ 123 (123)      
Forfeitures of restricted shares (in shares)   (13,619)        
Forfeitures of restricted shares (417) $ (13) (404)      
Share-based compensation 6,869   6,869      
Purchase of treasury shares (in shares)           555,692
Purchase of treasury shares (33,594)         $ (33,594)
Net income 197,769     197,769    
Dividends on common shares (27,704)     (27,704)    
Other comprehensive (loss) income during the period 23,233       23,233  
Common stock, balance at end of period (in shares) at Jun. 30, 2025   72,897,371        
Balance at end of period at Jun. 30, 2025 3,917,678 $ 72,897 1,964,896 2,023,493 (6,886) $ (136,722)
Treasury stock, balance at end of period (in shares) at Jun. 30, 2025           4,186,328
Common stock, balance at beginning of period (in shares) at Mar. 31, 2025   72,884,780        
Balance at beginning of period at Mar. 31, 2025 3,823,802 $ 72,885 1,961,732 1,927,489 (14,430) $ (123,874)
Treasury stock, balance at beginning of period (in shares) at Mar. 31, 2025           3,973,856
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted shares (in shares)   12,591        
Issuance of restricted shares 0 $ 12 (12)      
Share-based compensation 3,176   3,176      
Purchase of treasury shares (in shares)           212,472
Purchase of treasury shares (12,848)         $ (12,848)
Net income 109,834     109,834    
Dividends on common shares (13,830)     (13,830)    
Other comprehensive (loss) income during the period 7,544       7,544  
Common stock, balance at end of period (in shares) at Jun. 30, 2025   72,897,371        
Balance at end of period at Jun. 30, 2025 $ 3,917,678 $ 72,897 1,964,896 2,023,493 (6,886) $ (136,722)
Treasury stock, balance at end of period (in shares) at Jun. 30, 2025           4,186,328
Common stock, balance at beginning of period (in shares) at Dec. 31, 2025 72,898,342 72,898,342        
Balance at beginning of period at Dec. 31, 2025 $ 4,076,028 $ 72,898 1,971,131 2,210,385 8,312 $ (186,698)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2025 4,876,026         4,876,026
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted shares (in shares)   211,505        
Issuance of restricted shares $ 0 $ 212 (212)      
Issuance of common shares pursuant to PSU agreements (in shares)   161,712        
Issuance of common shares pursuant to PSU agreements 0 $ 162 (162)      
Forfeitures of restricted shares (in shares)   (6,686)        
Forfeitures of restricted shares (92) $ (7) (85)      
Share-based compensation 7,901   7,901      
Purchase of treasury shares (in shares)           1,282,260
Purchase of treasury shares (103,347)         $ (103,347)
Net income 161,938     161,938    
Dividends on common shares (27,031)     (27,031)    
Other comprehensive (loss) income during the period $ (24,820)       (24,820)  
Common stock, balance at end of period (in shares) at Jun. 30, 2026 73,264,873 73,264,873        
Balance at end of period at Jun. 30, 2026 $ 4,090,577 $ 73,265 1,978,573 2,345,292 (16,508) $ (290,045)
Treasury stock, balance at end of period (in shares) at Jun. 30, 2026 6,158,286         6,158,286
Common stock, balance at beginning of period (in shares) at Mar. 31, 2026   73,251,984        
Balance at beginning of period at Mar. 31, 2026 $ 4,082,127 $ 73,252 1,973,881 2,307,358 (1,476) $ (270,888)
Treasury stock, balance at beginning of period (in shares) at Mar. 31, 2026           5,931,686
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted shares (in shares)   17,964        
Issuance of restricted shares 0 $ 18 (18)      
Forfeitures of restricted shares (in shares)   (5,075)        
Forfeitures of restricted shares (49) $ (5) (44)      
Share-based compensation 4,754   4,754      
Purchase of treasury shares (in shares)           226,600
Purchase of treasury shares (19,157)         $ (19,157)
Net income 51,446     51,446    
Dividends on common shares (13,512)     (13,512)    
Other comprehensive (loss) income during the period $ (15,032)       (15,032)  
Common stock, balance at end of period (in shares) at Jun. 30, 2026 73,264,873 73,264,873        
Balance at end of period at Jun. 30, 2026 $ 4,090,577 $ 73,265 $ 1,978,573 $ 2,345,292 $ (16,508) $ (290,045)
Treasury stock, balance at end of period (in shares) at Jun. 30, 2026 6,158,286         6,158,286